{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:51:32Z","timestamp":1793656292027,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.colsurfb.2021.111652","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T01:25:10Z","timestamp":1613870710000},"page":"111652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5548-766X","authenticated-orcid":false,"given":"Vikas","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-8257","authenticated-orcid":false,"given":"Rashmin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-6266","authenticated-orcid":false,"given":"Mrunali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Thanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2021.111652_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1591-9","article-title":"Mechanistic insights of formulation approaches for the treatment of nail infection: conventional and novel drug delivery approaches","volume":"21","author":"Vikas","year":"2020","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/jof5010020","article-title":"Recent findings in onychomycosis and their application for appropriate treatment","volume":"5","author":"Monod","year":"2019","journal-title":"J. Fungi."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jof1010030","article-title":"Onychomycosis: a review","volume":"1","author":"Piraccini","year":"2015","journal-title":"J. Fungi."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cpm.2016.02.001","article-title":"Onychomycosis: evaluation, treatment options, managing recurrence, and patient outcomes","volume":"33","author":"Vlahovic","year":"2016","journal-title":"Clin. Podiatr. Med. Surg."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0897190016630904","article-title":"Efinaconazole and tavaborole: emerging antifungal alternatives for the topical treatment of onychomycosis","volume":"30","author":"Poulakos","year":"2017","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaad.2018.03.062","article-title":"Onychomycosis: clinical overview and diagnosis","volume":"80","author":"Lipner","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/1346-8138.14935","article-title":"Efficacy of long\u2010term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: a multicenter, single\u2010arm study","volume":"46","author":"Iozumi","year":"2019","journal-title":"J Dermatol."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0040","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/jps.24459","article-title":"Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis","volume":"104","author":"Bhatt","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0045","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1586\/14787210.2014.919852","article-title":"Efinaconazole (Jublia) for the treatment of onychomycosis","volume":"12","author":"Gupta","year":"2014","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/2211738507666190228104031","article-title":"Novel drug delivery strategies for the treatment of onychomycosis","volume":"7","author":"Dhamoon","year":"2019","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2017.05.005","article-title":"Microemulsion utility in pharmaceuticals: implications for multi-drug delivery","volume":"526","author":"Callender","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4172\/pharmaceutical-sciences.1000145","article-title":"D-optimal design and development of microemulsion based transungual drug delivery formulation of ciclopirox olamine for treatment of onychomycosis","volume":"78","author":"Chouhan","year":"2016","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0065","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1208\/s12249-017-0711-7","article-title":"Transungual gel of terbinafine hydrochloride for the management of onychomycosis: formulation, optimization, and evaluation","volume":"18","author":"Thatai","year":"2017","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0070","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/03639045.2014.931966","article-title":"Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis","volume":"41","author":"Pal","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110823","article-title":"Development of microemulsion based topical ivermectin formulations: pre-formulation and formulation studies","volume":"189","author":"Das","year":"2020","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.colsurfb.2021.111652_bib0080","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1208\/s12249-016-0488-0","article-title":"Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis","volume":"17","author":"Mahtab","year":"2016","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40005-018-0386-4","article-title":"QbD based development and evaluation of topical microemulsion-based hydrogel against superficial fungal infections","volume":"49","author":"Choi","year":"2019","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s13346-012-0109-8","article-title":"Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies","volume":"2","author":"Barot","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1208\/s12249-011-9742-7","article-title":"Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design","volume":"13","author":"Barot","year":"2012","journal-title":"Aaps. Pharm. Sci. Tech."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110681","article-title":"Cyclosporine laden tailored microemulsion-gel depot for effective treatment of psoriasis: in vitro and in vivo studies","volume":"186","author":"Pandey","year":"2020","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.colsurfb.2021.111652_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111103","article-title":"Development and skin penetration pathway evaluation of microemulsions for enhancing the dermal delivery of celecoxib","volume":"193","author":"Subongkot","year":"2020","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.colsurfb.2021.111652_bib0110","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3109\/10717544.2013.878857","article-title":"Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization","volume":"22","author":"Shah","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejps.2015.07.002","article-title":"Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters","volume":"78","author":"Shah","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.104753","article-title":"RP-HPLC method for quantitative estimation of efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in presence of its degradation products","volume":"155","author":"Vikas","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/10717544.2019.1687612","article-title":"Preparation and in vivo evaluation of a highly skin-and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis","volume":"26","author":"Lee","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13346-016-0287-x","article-title":"Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis","volume":"6","author":"Patel","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0135","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/jocd.13317","article-title":"Effect of monoterpenes on ex vivo transungual delivery of itraconazole for the management of onychomycosis","volume":"19","author":"Abdollahi","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40005-015-0209-9","article-title":"Microemulsion-based antifungal gel of luliconazole for dermatophyte infections: formulation, characterization and efficacy studies","volume":"46","author":"Kansagra","year":"2016","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.colsurfb.2021.111652_bib0145","article-title":"In vitro cytotoxic activity assay of bacteria extract derived marine sponge haliclona fascigera toward hela, WiDr, T47D, and vero cell line","volume":"9","author":"Sandrawati","year":"2019","journal-title":"In vitro"},{"key":"10.1016\/j.colsurfb.2021.111652_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.fct.2019.04.038","article-title":"Microemulsions of essentials oils\u2013Increase of solubility and antioxidant activity or cytotoxicity?","volume":"129","author":"Sieniawska","year":"2019","journal-title":"Food Chem. Toxicol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776521000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776521000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:58:32Z","timestamp":1760525912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776521000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"alternative-id":["S0927776521000965"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111652","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111652"}}